Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with RPRX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
RPRX
Royalty Pharma plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 499d
Method
›
Moved together
LLY
with
RPRX
×0.21
co-movement · RPRX on LLY · 499d
r 0.34
scale to r 0.75
Shared co-movers
7
with LLY
with RPRX
AMGN
Amgen Inc
r 0.41
r 0.41
NVS
Novartis AG
r 0.39
r 0.40
MRK
Merck & Co., Inc.
r 0.42
r 0.37
BMY
Bristol Myers Squibb Co
r 0.37
r 0.35
GSK
GSK plc
r 0.37
r 0.35
BIIB
Biogen Inc.
r 0.40
r 0.34
LLY, solid
RPRX, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,408.05
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
RPRX
Royalty Pharma plc
Change
66.32
▼
−0.30%
· post 66.32
· delayed
After hours
Nov 3 '26
Mkt cap
$38.2B
Revenue
$674M
Q2 FY26
Revenue
$2.4B
FY25
vs
Compare
After hours
Nov 3 '26
LLY
ELI Lilly & Co
vs
RPRX
Royalty Pharma plc
1,407.25
▼
−0.27%
post 1,408.05
Price
66.32
▼
−0.30%
post 66.32
delayed
$1.3T
Mkt cap
$38.2B
Q3 FY26
$24.4B
Revenue
$674M
Q2 FY26
FY25
$65.2B
Revenue
$2.4B
FY25
Change
Change
LLY
1,407.25
▼
−0.27%
vs
RPRX
66.32
▼
−0.30%
After hours
Nov 3 '26